| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.24 | 0.5 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.13 | 0.5 |